BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28780159)

  • 1. Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms.
    Siddiqui-Jain A; Hoj JP; Hargiss JB; Hoj TH; Payne CJ; Ritchie CA; Herron SR; Quinn C; Schuler JT; Hansen MDH
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3992-4000. PubMed ID: 28780159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecules Revealed in a Screen Targeting Epithelial Scattering Are Inhibitors of Microtubule Polymerization.
    Hoj TH; Robinson RJ; Burton JC; Densley-Ure RA; Olson TV; Williams LK; Coward L; Gorman G; Hansen MD
    J Biomol Screen; 2016 Aug; 21(7):671-9. PubMed ID: 27245142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, Synthesis and Screening of 4,6-Diaryl Pyridine and Pyrimidine Derivatives as Potential Cytotoxic Molecules.
    Abd Elhameid MK; Ryad N; Al-Shorbagy MY; Mohammed MR; Ismail MM; El Meligie S
    Chem Pharm Bull (Tokyo); 2018 Oct; 66(10):939-952. PubMed ID: 30111667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.
    Siddiqui-Jain A; Hoj JP; Cescon DW; Hansen MD
    Bioorg Med Chem Lett; 2018 Mar; 28(5):934-941. PubMed ID: 29433928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines.
    Leonel C; Ferreira LC; Borin TF; Moschetta MG; Freitas GS; Haddad MR; de Camargos Pinto Robles JA; Aparecida Pires de Campos Zuccari D
    Anticancer Agents Med Chem; 2017; 17(8):1113-1125. PubMed ID: 28042775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, and docking studies of phenylpyrimidine-carboxamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Wang J; Tang Q; Wu C; Zhao Y; Zheng P
    Bioorg Med Chem; 2016 Apr; 24(8):1749-56. PubMed ID: 26964675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
    Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
    Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
    Kassab AE; Gedawy EM
    Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of pyridinyl-1H-1,2,3-triazolyldihydroisoxazoles as potent inhibitors of tubulin polymerization.
    Suman P; Murthy TR; Rajkumar K; Srikanth D; Dayakar Ch; Kishor C; Addlagatta A; Kalivendi SV; Raju BC
    Eur J Med Chem; 2015 Jan; 90():603-19. PubMed ID: 25499929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of intrinsic apoptosis pathway in colon cancer HCT-116 cells by novel 2-substituted-5,6,7,8-tetrahydronaphthalene derivatives.
    Gamal-Eldeen AM; Hamdy NA; Abdel-Aziz HA; El-Hussieny EA; Fakhr IM
    Eur J Med Chem; 2014 Apr; 77():323-33. PubMed ID: 24657569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of thiazole linked indolyl-3-glyoxylamide derivatives as tubulin polymerization inhibitors.
    Guggilapu SD; Guntuku L; Reddy TS; Nagarsenkar A; Sigalapalli DK; Naidu VGM; Bhargava SK; Bathini NB
    Eur J Med Chem; 2017 Sep; 138():83-95. PubMed ID: 28648953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and anti-cancer activities of 2-[1-(indol-3-yl-/pyrimidin-5-yl-/pyridine-2-yl-/quinolin-2-yl)-but-3-enylamino]-2-phenyl-ethanols.
    Singh P; Kaur P; Luxami V; Kaur S; Kumar S
    Bioorg Med Chem; 2007 Mar; 15(6):2386-95. PubMed ID: 17275313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
    Nagender P; Malla Reddy G; Naresh Kumar R; Poornachandra Y; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2905-8. PubMed ID: 24835633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel trifluoromethyl substituted furo[2,3-b]pyridine and pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as potential anticancer agents.
    Naresh Kumar R; Poornachandra Y; Nagender P; Mallareddy G; Ravi Kumar N; Ranjithreddy P; Ganesh Kumar C; Narsaiah B
    Eur J Med Chem; 2016 Jan; 108():68-78. PubMed ID: 26629861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of new diarylamides with pyrimidinyl pyridine scaffold and evaluation of their anti-proliferative effect on cancer cell lines.
    Abdelazem AZ; Al-Sanea MM; Park HM; Lee SH
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1301-4. PubMed ID: 26786696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Novel Pyrido[1,2-a]pyrimidine-3-carboxamide Derivatives and Their Anticancer Activity.
    Santhosh Kumar G; Jitender Dev G; Ravi Kumar N; Krishna Swaroop D; Poorna Chandra Y; Ganesh Kumar C; Narsaiah B
    Chem Pharm Bull (Tokyo); 2015; 63(8):584-90. PubMed ID: 26235166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
    Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
    Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of imidazo[1,5-a]pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K/Akt pathway.
    Kamal A; Rao AV; Nayak VL; Reddy NV; Swapna K; Ramakrishna G; Alvala M
    Org Biomol Chem; 2014 Dec; 12(48):9864-80. PubMed ID: 25354805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents.
    Zhou W; Huang A; Zhang Y; Lin Q; Guo W; You Z; Yi Z; Liu M; Chen Y
    Eur J Med Chem; 2015; 96():269-80. PubMed ID: 25899332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.